AmyDanaShapiroMD
Pediatric Hematology & Oncology • Indianapolis, INPediatric Coagulation Disorder Hematology
Medical Director CEO Indiana Hemophilia & Thrombosis Center
Dr. Shapiro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Indiana Hemophilia & Thrombosis Center
8326 Naab Road
Indianapolis, IN 46260- Is this information wrong?
Education & Training
University of ColoradoFellowship, Pediatric Hematology/Oncology, 1983 - 1987- University of ColoradoResidency, Pediatrics, 1980 - 1983
New York University School of MedicineClass of 1980
Certifications & Licensure
IN State Medical License 1987 - 2025
CO State Medical License 1983 - 1987- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery Start of enrollment: 2001 Feb 12
- Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients Start of enrollment: 2013 May 22
- Inhibitor Development in Patients With Hemophilia A Undergoing Surgery Start of enrollment: 2011 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Severe FVII deficiency presenting with heterotopic gastric mucosa: hoofbeats may be a zebra.Sweta Gupta, Amy D Shapiro, Eric E Tibesar> ;Haemophilia. 2023 May 1
- 16 citationsEmicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study.Claude Négrier, Johnny Mahlangu, Michaela Lehle, Pratima Chowdary, Olivier Catalani, Ronald J Bernardi, Víctor Jiménez-Yuste, Benjamin M Beckermann, Christophe Schmitt...> ;The Lancet. Haematology. 2023 Mar 1
- 3 citationsManaging surgery in hemophilia with recombinant factor VIII Fc and factor IX Fc: Data on safety and effectiveness from phase 3 pivotal studies.Pratima Chowdary, Margareta Holmström, Johnny N Mahlangu, Margaret C Ozelo, Ingrid Pabinger, K John Pasi, Margaret V Ragni, Amy Shapiro, Chris Barnowski, Stefan Lethagen> ;Research and Practice in Thrombosis and Haemostasis. 2022 Jul 1
- Join now to see all
Lectures
- On-Demand Treatment of Bleeding Episodes in Patients with Hereditary Factor X Deficiency Using a High-Purity Factor X Concentrate: Data from 2 Clinical Trials and a Da...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- B-YOND Final Results Confirm Established Safety, Sustained Efficacy, and Extended Dosing Interval for Up to 4 Years of Treatment With rFIXFc in Previously Treated Subj...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Gene Found in Indiana Amish Could Help Find Drug for LongevityNovember 27th, 2017
Amish Mutation Protects Against Diabetes and May Extend LifeNovember 23rd, 2017
Genetic Mutation in Extended Amish Family Gives Them Longer LifeNovember 18th, 2017- Join now to see all
Hospital Affiliations
Memorial Hospital of South BendSouth Bend, Indiana
Indiana University Health University HospitalIndianapolis, Indiana
Indiana University Health North HospitalCarmel, Indiana
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
